新型致病性GCH1变体在家族DOPA-响应性 dystonia 中
Johanna Engel1, Ivana Dzinovic2,3, Michael Zech2,3,4
1Department of Pediatric Neurology and Muscle Disorders, University Hospital Freiburg, Freiburg, Germany.
Neuropediatrics
|November 14, 2025
概括
这项研究确定了一种新的GCH1基因变异,导致DOPA反应性 dystonia (DRD),症状变化. 通过家族病史及识别白天症状变化的早期诊断对于有效的L-DOPA治疗至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 分子生物学分子生物学
背景情况:
- 对DOPA敏感的 dystonia (DRD) 是一种可治疗的神经疾病,由于其可变的表现,经常被误诊.
- 现型异质性可能会延迟诊断和适当的L-DOPA治疗.
研究的目的:
- 为了研究两个青少年女性的渐进性步态障碍的遗传基础.
- 突出DRD的表型变异性,并强调诊断线索.
主要方法:
- 临床评估,包括步行障碍评估和日间症状跟踪.
- 神经轴MRI用于排除中枢神经系统异常.
- 基因检测 (GCH1变体识别) 和RNA测序用于拼接缺陷分析.
主要成果:
- 在受影响的家庭成员中发现了相同的内部GCH1变异,导致拼接缺陷.
- 在三代的六名女性中确诊了DRD.
- 强大的临床改善与L-DOPA治疗.
结论:
- 已识别的GCH1变种与一种独特的DRD形式有关.
- 现型变异性和日间症状波动是DRD的关键诊断特征.
- 早期识别家族病史和症状模式有助于及时对DRD进行L-DOPA治疗.
更多相关视频
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Direct Motor Pathways
4.1K
The direct motor pathways, also known as the pyramidal tracts, are a group of neural pathways that originate in the brain and descend through the spinal cord. They control the voluntary movement of the body. There are two major direct motor pathways: the corticospinal and the corticobulbar tracts.
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
4.1K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
797
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
797


